Short antithrombotic therapy after stent implantation in high bleeding risk patients
Not Applicable
Completed
- Conditions
- Patients with coronary artery disease and indication for PCICirculatory SystemAtherosclerotic heart disease
- Registration Number
- ISRCTN65588717
- Lead Sponsor
- niversity Hospital of Muenster
- Brief Summary
2020 Results article in https://pubmed.ncbi.nlm.nih.gov/31965195/ (added 27/09/2021)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 89
Inclusion Criteria
1. Implantation of at least one Biofreedom® stent for the treatment of significant CAD during the study period
2. At least one criterion for high risk bleeding
Exclusion Criteria
1. Aged <18 years
2. Current pregnancy
3. Underlying malignant disease
4. Active bleeding
5. Unable to give informed consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> 1. Safety of a short antithrombotic therapy after stent implantation, measured using a standardized questionnaire at a single follow-up timepoint<br> 2. Efficacy of short antithrombotic therapy, measured using a standardized questionnaire at a single follow-up timepoint<br>
- Secondary Outcome Measures
Name Time Method Risk factors for events (bleeding or thrombotic), measured using a standardized questionnaire at a single follow-up timepoint